Resistance and support
64.73
![](https://www.icicidirect.com/Content/images/graph17.png)
CLIENT NAME | DEAL TYPE | ACTION | DATE | AVG. PRICE | QUANTITY | EXCHANGE |
---|---|---|---|---|---|---|
SHRI BAJRANGBALI ASHOK CONSTRUCTION PRIVATE LIMITED | Bulk | Sell | 2024-08-14 | 66.06 | 42000 | NSE |
SHRI BAJRANGBALI ASHOK CONSTRUCTION PRIVATE LIMITED | Bulk | Purchase | 2024-08-12 | 130.5 | 100000 | NSE |
SEJAL KALPESH LADHAWALA | Bulk | Sell | 2024-08-12 | 130.5 | 68000 | NSE |
Financials( ₹ in Cr) | Walpar Nutritions Ltd | Sun Pharmaceuticals Industries Ltd | Cipla Ltd | Divis Laboratories Ltd | Zydus Lifesciences Ltd |
---|---|---|---|---|---|
Price | 64.60 | 1,742.75 | 1,576.10 | 4,633.90 | 1,187.55 |
% Change | -1.75 | 0.06 | 0.79 | -0.60 | 1.46 |
Mcap ₹ Cr | 30.33 | 418,144.11 | 127,272.91 | 123,015.68 | 119,495.32 |
Revenue TTM ₹ Cr | 62.52 | 48,496.85 | 25,774.09 | 7,845.00 | 19,547.40 |
Net Profit TTM ₹ Cr | 1.95 | 9,648.44 | 4,155.31 | 1,600.00 | 3,854.40 |
PE TTM | 39.63 | 39.65 | 28.64 | 73.50 | 28.66 |
1 Year Return | 33.33 | 53.65 | 27.56 | 24.21 | 85.08 |
ROCE | 14.25 | 17.20 | 22.27 | 16.41 | 23.94 |
ROE | 15.06 | 16.13 | 16.58 | 12.15 | 20.64 |
Equity Capital: 14.19 Cr FV: 10.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 37,516.17 | -14,555.25 |
LAST 3M | 90,902.40 | 37,557.41 |
LAST 6M | 198,345.87 | 43,710.77 |
LAST 12M | 329,168.77 | 54,053.10 |
Date | Action Type | Ratio |
---|---|---|
Aug 14, 2024 | Bonus | 1:1 |
The Company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of "M/s Walpar Healthcare", pursuant to a Deed of Partnership dated November 16, 2009. Subsequently, the Constitution of Partnership Firm were changed on March 9, 2015, August 15, 2017 and June 12, 2020 by admission and retirement of Partners. "M/s. Walpar Healthcare" was thereafter incorporated and converted from a erstwhile Partnership Firm to a Public Limited Company under Part I Chapter XXI of the Companies Act, 2013 in the name of "Walpar Nutritions Limited" and received a Certificate of Incorporation dated December 4th, 2020 from the Central Registration Center, Ministry of Corporate Affairs. The Company is primarily engaged in manufacturing, marketing and trading of Pharmaceuticals, Nutraceutical, Herbal and Ayurvedic commodities online and offline. During the year 2021, the Company allotted 3,41,220 Equity Shares of having Face Value of Rs. 10/- each at a price of Rs. 50/- per share including premium of Rs. 40/- per share on preferential basis.
2nd Floor L5 377 Plot 5 Opp., Sabarmati Village: Khatraj, Gandhinagar, Gujarat, 382721
Tel | : | 91-2764-66262 |
: | finance.walpar:hotmail.com | |
Website | : | http://www.walparnutritions.com |
Skyline Financial Services Pvt
AGM Date (Month) | : | Dec |
Face Value Equity Shares | : | 10 |
Market Lot Equity Shares | : | 2000 |
BSE Code | : | 535385 |
NSE Code | : | WALPAR |
Book Closure Date (Month) | : | Sep |
BSE Group | : | |
ISIN | : | INE0G2G01015 |
You can buy Walpar Nutritions Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Walpar Nutritions Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 16, 2024 03:32 PM the closing price of Walpar Nutritions Ltd was Rs.64.60.
The latest PE ratio of Walpar Nutritions Ltd as of Aug 16, 2024 03:32 PM is 39.63
The latest PB ratio of Walpar Nutritions Ltd as of Aug 16, 2024 03:32 PM is 0.23
The 52-week high of Walpar Nutritions Ltd share price is Rs. 76.98 while the 52-week low is Rs. 39.00
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Aug 16, 2024 03:32 PM, the market cap of Walpar Nutritions Ltd stood at Rs. 30.33 Cr.